DuChemBIO Co.,Ltd. (176750) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DuChemBIO Co.,Ltd. (176750:KRX), powered by AI.
- Current Price
- ₩6,600
- P/E Ratio
- 29.0
- Market Cap
- 188.0B
- Sector
- Healthcare
What is the DuChemBIO Co.,Ltd. stock price forecast?
DuChemBIO Co.,Ltd. is currently trading at ₩6,600. View real-time AI analysis on Alpha Lenz.
What is DuChemBIO Co.,Ltd. insider trading activity?
View the latest insider trading data for DuChemBIO Co.,Ltd. on Alpha Lenz.
What is DuChemBIO Co.,Ltd.'s P/E ratio?
DuChemBIO Co.,Ltd.'s P/E ratio is 29.0.
DuChemBIO Co.,Ltd.
KRX · 176750“DuChemBIO Co.,Ltd. trades at a P/E of 29.0 (premium valuation) with solid ROE of 14.0%.”
Ask for details →Company Overview
DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson's disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amyloid in Alzheimer's disease. The company also offers FES, a solution for diagnosis of metastatic breast cancer and determination of estrogen receptor status; FACBC for prostate cancer diagnosis; FDG for the diagnosis of tumors; and NaF for the diagnosis of bone-related diseases. DuChemBIO Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“DuChemBIO Co.,Ltd. trades at a P/E of 29.0 (premium valuation) with solid ROE of 14.0%.”
Ask for details →Frequently Asked Questions
DuChemBIO Co.,Ltd. (ticker: 176750) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 91 employees. Market cap is $188.0B.
The current price is ₩6,600 with a P/E ratio of 29.02x and P/B of 3.82x.
ROE is 14.05% and operating margin is 19.30%. Annual revenue is $38.6B.